ALS News Today highlights OHSU’s role in a new study which explores targeting the gene α5 integrin as an immunomodulatory treatment for the disease.
August 07, 2023
In a Precision Medicine story about a new platform for diagnosis and treatment involving genomics, Joseph Quinn, M.D., says it’s a viable idea, adding, “Whether it works in Parkinson’s disease remains to be seen.”